FDA Investigator: Ralph M. Bernstein
- Ralph M. Bernstein first started conducting FDA inspections in 2016, with the last inspection in 2024. Over that time, Ralph M. Bernstein has conducted 6 inspections at 4 companies across 6 sites.
Get Ralph Bernstein's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Biocon Biologics Limited, Bengaluru | 2022
Out-of-stock
Ralph M. Bernstein
Human Drug Form 483
FDA 483 Biocon Biologics Limited, Bengaluru | 2022
Out-of-stock
Ralph M. Bernstein
Human Drugs Form 483
FDA 483 Celltrion Inc., Yeonsu | 2022
Out-of-stock
Ralph M. Bernstein
Human Drug Form 483
FDA 483 KBI Biopharma, Inc., Boulder | 2018
Out-of-stock
Ralph M. Bernstein
Human Drug Form 483
FDA 483 Xcelience LLC, Tampa | 2016
Out-of-stock
Ralph M. Bernstein
Human Drug Form 483
Co-Investigators (11)
- Zhong Li, FDA Investigator
- Saleem A. Akhtar, FDA Investigator
- Hyung-Yul Lee, FDA Investigator
- Hao Kiet Phan,
- Michael Shanks, FDA Investigator
- Arsen Karapetyan, FDA Investigator
- Wayne E. Seifert, FDA Investigator
- Junho Pak, FDA Investigator
- Jamie L. Dion, FDA Investigator
- Scott R. Nichols, FDA Investigator
- Joanne E. King, FDA Investigator